Delays in diagnosis and melanoma prognosis (I): The role of patients

International Journal of Cancer

Volumn 89, Issue 3, 2000, Pages 271-279

  Richard, Marie A ^a   Grob, Jean J ^a   Avril, Marie F ^b   Delaunay, Michèle ^c   Gouvernet, Johany ^d   Wolkenstein, Pierre ^e   Souteyrand, Pierre ^f   Dreno, Brigitte ^g   Bonerandi, Jean J ^d   Dalac, Sophie ^h   Machet, Laurent ⁱ   Guillaume, Jean C ^j   Chevrant Breton, Jacqueline ^k   Vilmer, Catherine ^l   Aubin, François ^m   Guillot, Bernard ⁿ   Beylot Barry, Marie ^o   Lok, Catherine ^p   Raison Peyron, Nadia ^q   Chemaly, Philippe ^r  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c HÔPITAL PELLEGRIN   (France)

^d TIMONE HOSPITAL   (France)

^e HENRI MONDOR HOSPITAL   (France)

^f HÔTEL DIEU   (France)

^g HÔTEL DIEU   (France)

^h HÔPITAL DU BOCAGE   (France)

ⁱ SERVICE DE DERMATOLOGIE   (France)

^j Pasteur Hospital   (France)

^k Hotel Dieu CHU Rennes   (France)

^l CENTRE RENÉ HUGUENIN   (France)

^m HÔPITAL SAINT JACQUES   (France)

ⁿ DEPARTMENT OF NEUROLOGY   (France)

^o Service de Dermatologie   (France)

^p AMIENS UNIVERSITY HOSPITAL   (France)

^q Hopital Saint Charles   (France)

^r SAINT LOUIS HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SCREENING; CANCER SIZE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HEALTH BEHAVIOR; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; SELF EXAMINATION; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PATIENT EDUCATION; PATIENT PARTICIPATION; PATIENTS; PROSPECTIVE STUDIES; SKIN NEOPLASMS; TIME FACTORS;

EID: 0033933637     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000520)89:3<271::AID-IJC10>3.0.CO;2-7     Document Type: Article

References (20)

1. ARMENTROUT, J., Correspondence of the MMPI and Mini-Mult in a college population. J. Clin. Pyschol., 26, 493-495 (1970).
2. BACCARD, M., CHEVRET, S., CHEMALY, P., and MOREL, P., Délai de diagnostic du mélanome. Etude prospective de 102 malades. Ann. Dermatol. Vénéréol., 124, 601-606 (1997).
3. BASTUJI-GARIN, S., ARCAN, J.C., DELLIERE, A., BONERANDI, J.J., and REVUZ, J., Les Français et le soleil: évolution des connaissances et des comportements. Journées Dermatologiques de Paris. Ann. Dermatol. Vénéréol., 125, 3S66 (1998).
4. CASSILETH, B.R., TEMOSHOK, L., FREDERICK, B.E., WALSH, W.P., HURWITZ, S., GUERRY, D.P., CLARK, W.H., DICLEMENTE, R.J., SWEET, D.M., BLOIS, M.S., and SAGEBIEL, R.W., Patient and physician delay in melanoma diagnosis. J. Amer. Acad. Dermatol., 18, 591-598 (1988).
5. DOHERTY, V.R. and MACKIE, R.M., Reasons for poor prognosis in British patients with cutaneous malignant melanoma. Brit. Med. J., 292, 987-989 (1986).
6. FASCHINGBAUER, T.R., Substitution and regression models, base rates, and the clinical validity of the Mini-Mult. J. Clin. Psychol., 32, 70-74 (1976).
7. GROB, J.J., Cost effectiveness in skin cancers prevention. In: P. Altmeyer, K. Hoffmann, and M. Stker (eds.), Skin cancer and UV radiation, pp. 902-908, Springer-Verlag, Berlin Heidelberg (1997).
8. HALL, H.I., MILLER, DR., ROGERS, J.D., BEWERSE, B., Update on the incidence and mortality from melanoma in the United States. J. Amer. Acad. Dermatol., 40, 35-42 (1999).
9. HENNRIKUS, D., GIRGIS, A., REDMAN, S., and SANSON-FISHER, R.W., A community study of delay in presenting with signs of melanoma to medical practitioners. Arch. Dermatol., 127, 356-361 (1991).
10. KOH, H.K., MILLER, D.R., GELLER, A.C., CLAPP, R.W., MERCER, M.B., and LEW, R.A., Who discovers melanoma? Patterns from a population-based study. J. Amer. Acad. Dermatol., 26, 914-919 (1992).
11. KRIGE, J.E.J., ISAACS, S., HUDSON, D.A., KING, H.S., STROVER, R.M., and JOHNSON, C.A., Delay in the diagnosis of cutaneous malignant melanoma. A prospective study in 250 patients. Cancer, 68, 2064-2068 (1991).
12. LANGLEY, R.G.B. and SOBER, A.J., Causes for the delay in diagnosis of melanoma. In: J.J. Grob, R.S. Stern, R.M. Mackie, and W.A. Weinstock (eds.), Epidemiology, causes and prevention of skin diseases, pp. 177-183, Blackwell Science, London (1997).
13. MASRI, G.D., CLARK, W.H., GUERRY IV, D.P., HALPERN, A., THOMPSON, C.J., and ELDER, D.E., Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J. Amer. Acad. Dermatol., 22, 1042-1048 (1990).
14. NEWMAN, S., NICHOLS, S., FREER, C., and IZZARD, L., How much do the public know about moles, skin cancer, and malignant melanoma? The results of a postal survey. Commun. Med., 10, 351-357 (1988).
15. RAMPEN, F.H.J., RÜMKE, P., and HART, A.A.M., Patients' and doctors' delay in the diagnosis and treatment of cutaneous melanoma. Europ. J. Surg. Oncol., 15, 143-148 (1989).
16. RICHARD, M.A., MARTIN, S., GOUVERNET, J., FOLCHETTI, G., BONERANDI, J.J., and GROB, J.J., Humour and alarmism in melanoma prevention: a randomized controlled study of three types of information leaflet. Brit. J. Dermatol., 140, 909-914 (1999a).
17. RICHARD M.A. and 19 OTHERS, Melanoma and tumor thickness. Challenges of early diagnosis. Arch. Dermatol., 135, 269-274 (1999b).
18. STADELMANN, W.K., RAPAPORT, D.P., SOONG, S.J., REINTGKN, D.S., BUZAID, A.C., and BALCH, C.M., Prognostic clinical and pathologic features in cutaneous melanoma. In: C.M. Balch, A.N. Houghton, A.J. Sober, and S.J. Soong.(eds.), Cutaneous melanoma, 3rd ed., pp. 11-35, Quality Medical Publishing, St. Louis (1998).
19. TEMOSHOK, L., DICLEMENTE, R.J., SWEET, D.M., BLOIS, M.S., and SAGEBIEL, R. W., Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma. Cancer, 54, 3048-3053 (1984).
20. TEMOSHOK, L., Biopsychosocial studies on cutaneous malignant melanoma: psychological factors associated with prognostic indicators, progression, psychophysiology and tumor-host response. Medicine, 8, 833-840 (1985).